Aurinia Pharmaceuticals Statistics
Total Valuation
AUPH has a market cap or net worth of $727.43 million. The enterprise value is $472.38 million.
| Market Cap | 727.43M |
| Enterprise Value | 472.38M |
Important Dates
The next confirmed earnings date is Thursday, May 2, 2024, before market open.
| Earnings Date | May 2, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AUPH has 144.62 million shares outstanding. The number of shares has increased by 0.93% in one year.
| Shares Outstanding | 144.62M |
| Shares Change (YoY) | +0.93% |
| Shares Change (QoQ) | +0.59% |
| Owned by Insiders (%) | 7.45% |
| Owned by Institutions (%) | 38.52% |
| Float | 131.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.13 |
| Forward PS | 3.17 |
| PB Ratio | 1.92 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.50, with a Debt / Equity ratio of 0.26.
| Current Ratio | 5.50 |
| Quick Ratio | 4.85 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -26.92 |
Financial Efficiency
Return on equity (ROE) is -20.10% and return on invested capital (ROIC) is -19.28%.
| Return on Equity (ROE) | -20.10% |
| Return on Assets (ROA) | -14.80% |
| Return on Capital (ROIC) | -19.28% |
| Revenue Per Employee | $585,043 |
| Profits Per Employee | -$260,067 |
| Employee Count | 300 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 0.44 |
Taxes
In the past 12 months, AUPH has paid $551,000 in taxes.
| Income Tax | 551,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.21% in the last 52 weeks. The beta is 1.38, so AUPH's price volatility has been higher than the market average.
| Beta (1Y) | 1.38 |
| 52-Week Price Change | -53.21% |
| 50-Day Moving Average | 5.41 |
| 200-Day Moving Average | 7.94 |
| Relative Strength Index (RSI) | 44.47 |
| Average Volume (30 Days) | 2,093,138 |
Short Selling Information
The latest short interest is 12.24 million, so 8.47% of the outstanding shares have been sold short.
| Short Interest | 12.24M |
| Short Previous Month | 10.65M |
| Short % of Shares Out | 8.47% |
| Short % of Float | 9.29% |
| Short Ratio (days to cover) | 7.53 |
Income Statement
In the last 12 months, AUPH had revenue of $175.51 million and -$78.02 million in losses. Loss per share was -$0.54.
| Revenue | 175.51M |
| Gross Profit | 161.37M |
| Operating Income | -91.69M |
| Pretax Income | -77.47M |
| Net Income | -78.02M |
| EBITDA | -63.05M |
| EBIT | -74.69M |
| Loss Per Share | -$0.54 |
Balance Sheet
The company has $350.49 million in cash and $97.61 million in debt, giving a net cash position of $252.88 million or $1.75 per share.
| Cash & Cash Equivalents | 350.49M |
| Total Debt | 97.61M |
| Net Cash | 252.88M |
| Net Cash Per Share | $1.75 |
| Equity / Book Value | 377.95M |
| Book Value Per Share | 2.61 |
| Working Capital | 347.61M |
Cash Flow
In the last 12 months, operating cash flow was -$33.46 million and capital expenditures -$718,000, giving a free cash flow of -$34.18 million.
| Operating Cash Flow | -33.46M |
| Capital Expenditures | -718,000 |
| Free Cash Flow | -34.18M |
| FCF Per Share | -$0.24 |
Margins
Gross margin is 91.94%, with operating and profit margins of -52.24% and -44.45%.
| Gross Margin | 91.94% |
| Operating Margin | -52.24% |
| Pretax Margin | -44.14% |
| Profit Margin | -44.45% |
| EBITDA Margin | -35.92% |
| EBIT Margin | -42.56% |
| FCF Margin | -19.47% |
Dividends & Yields
AUPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.93% |
| Shareholder Yield | -0.93% |
| Earnings Yield | -10.76% |
| FCF Yield | -4.71% |
Analyst Forecast
The average price target for AUPH is $10.33, which is 105.37% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.33 |
| Price Target Difference | 105.37% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 25.12% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 23, 2013. It was a reverse split with a ratio of 1:50.
| Last Split Date | Oct 23, 2013 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
AUPH has an Altman Z-Score of 0.78 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.78 |
| Piotroski F-Score | 2 |